Clinical Trials Directory

Trials / Completed

CompletedNCT01346891

Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia

Status
Completed
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Hospital Italiano de Buenos Aires · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to detect if there are any differences in the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.

Detailed description

This is a Case Control study to compare the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.

Conditions

Timeline

Start date
2010-07-01
First posted
2011-05-03
Last updated
2011-07-06

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT01346891. Inclusion in this directory is not an endorsement.